PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9950898-0	1999	Effect of azelastine on platelet-activating factor-induced microvascular leakage in rat airways.	azelastine	10-20	PCNA clamp associated factor	Rattus norvegicus	24-50	
9950898-4	1999	Pretreatment with azelastine inhibited PAF-induced vascular leakage without affecting neutrophil accumulation.	azelastine	18-28	PCNA clamp associated factor	Rattus norvegicus	39-42	
9950898-6	1999	PAF increased neutrophil elastase contents in bronchoalveolar lavage fluid, an effect that was inhibited by azelastine.	azelastine	108-118	PCNA clamp associated factor	Rattus norvegicus	0-3	
9950898-7	1999	Therefore, azelastine attenuates PAF-induced airway mucosal microvascular leakage, probably involving inhibition of the release of neutrophil elastase from activated neutrophils.	azelastine	11-21	PCNA clamp associated factor	Rattus norvegicus	33-36	
8381149-12	1993	Furthermore, drugs that share the ability to impair PAF-induced eosinophilia, including azelastine and cetirizine, prevented the inhibitory effect of PAF on the antigen-induced pleurisy.	azelastine	88-98	PCNA clamp associated factor	Rattus norvegicus	52-55	
8381149-12	1993	Furthermore, drugs that share the ability to impair PAF-induced eosinophilia, including azelastine and cetirizine, prevented the inhibitory effect of PAF on the antigen-induced pleurisy.	azelastine	88-98	PCNA clamp associated factor	Rattus norvegicus	150-153	
1355732-18	1992	It was concluded that the ability of azelastine to antagonize histamine and PAF is important for its effectiveness against anaphylactic shock.	azelastine	37-47	PCNA clamp associated factor	Rattus norvegicus	76-79